Sobre Mí

MIEMBRO DE ORGANISMOS Y SOCIEDADES MÉDICAS

– Asociación Española de Cirugía (AEC)

– International Society of Surgery (ISS)

– Sociedad Española de la Cirugía de la Obesidad y enfermedades metabólicas (SECO)

– European Society of Endocrine Surgeons (ESES)

– International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)

– Reviewer of the EAC-BS Accreditation Review Committee

INVESTIGACIÓN

 

Publicaciones científicas en revistas internacionales : 82

Publicaciones científicas en revistas nacionales: 46

Comunicaciones a Congresos Nacionales: 132

Comunicaciones a Congresos Internacionales: 60

Capítulos de libros: 5

Formación

Licenciado en Medicina y Cirugia  por la Universidad Autónoma de Barcelona en 1980 con el grado de excelente.

 

Certificación extranjera ECFMG (Educational Commission for Foreign Medical Graduates; 3624 Market Street, Philadelphia, Pennsylvania 19104-2685. U.S.A.) en 1981

 

Certificación extranjera V.Q.E. ( Visa Qualifying Examination ) expedida en Londres por NBME (National Board of Medical Examiners) en 1983

 

Especialista en Cirugia General y del Aparato Digestivo en 1987 tras completar el Programa Nacional de Especialidades Médicas (MIR) de cinco años en el Hospital Vall d´Hebron de Barcelona.

 

Especialista en Coloproctología por St. Mark’s Hospital for Diseases of Rectum and Colon (Sir Charles Clore Centre for Postgraduate Studies, City Road, London) en 1988

 

Doctor en Medicina y Cirugía por la Universidad Autónoma de Barcelona en 1992 con el grado de apto cum laude

Tesis doctoral: “Cambios en el tránsito intestinal y colónico en pacientes colecistectomizados”.

 

Especialista en Cirugía Endocrina (glándulas tiroides, paratiroides y suprarrenales) y Jefe de la Unidad de Cirugía Endocrina, Metabólica y Bariátrica del Hospital Vall d´Hebron de Barcelona con más de 3.000 cirugías realizadas.

 

Especialista en Cirugía Bariátrica y Metabólica (obesidad y enfermedades realacionadas) y Jefe de la Unidad de Cirugía Endocrina, Metabólica y Bariátrica del Hospital Vall d´Hebron de Barcelona con 2.000 intervenciones quirúrgicas realizadas.

 

Cirujano de Excelencia en Cirugía Bariátrica y Metabólica por la European Accrediatation Council for Bariatric Surgery  (EAC-BS) (International Federation for Surgery of Obesity- Centre Of Excellence Program) (IFSO-COE program) .

Certificate No : 10017401411. April 22, 2011

 

Experto en Cirugia Robótica DaVinci. Diploma acreditativo entregado en Granada en 2009 ( nº de registre 90010165 ) con 10 años de experiencia y 500 cirugías bariátricas robóticas que le convierte en el referente nacional de esta especialidad quirúrgica.

Publicaciones científicas recientes relevantes

Seasonal variation of body weight loss after bariatric surgery.

Chronobiol Int 2019; 36 (5) : 672-680

 

Decreased TLR3 in hyperplastic adipose tissue. Blood and inflamed adipocytes is related to metabolic inflammation.

Cell Phisiol Biochem 2018; 51 (3): 1051-1068

 

Seasonal variations of changes in lipid and glucidic variables after bariatric surgey.

Chronobiol Int 2019; 36 (2) : 250-257

 

Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of literature.

Int J Surg case Rep 2018; 49: 145-148

 

Techincal options for malabsortion issues after single anastomosis duodenoileal bypass

with sleeve gastrectomy.

Obes Surg 2017 Dec;27 (12) 3344-3348.

 

Selective sentinel lymph node biopsy in papillary thyroid carcinoma in patients with no

preoperative evidence of lymph node metastasis.

Endocrinol Diabetes Nutr. 2017 Oct;64(8): 451-455.

 

Mid-term results and responsiveness predictors after two-step single-anastomosis

duodeno-ileal bypass with sleeve gastrectomy.

Obes Surg 2017 May; 27(5):1302-1308.

 

Biopsia selective del ganglio centinela en el carcinoma papilar de tiroides sin evidencia preoperatoriade metástasis gangilonar

Endocrinol Diabetes Nutr 2017. http://dx.doi.org/10.1016/j.endinu.2017.05.001

 

The role of morbid obesity in the promotion of metabolic disruptions and

 non-alcoholic steatohepatitis by Helicobacter Pylori.

PLoS One. 2016 Nov 28; 11(11):e0166741. Doi 10.1371/journal.pone.01666741.eCollection 2016

 

Bariatric surgery-induced weight loss in morbidly obese patients promotes a favorable

decrease in the gene expression of markers of subcutaneous adipose tissue homeostasis.

Atherosclerosis 2016; 252: e221

 

Robotically assisted single anastomosis duodeno-ileal by-ppass after previosu sleeve

gastrectomy. Implementing high valuable technology for complex procedures

J Obes 2015; 2015:586419. doi: 10.1155/2015/586419 Epub 2015 30

 

Hepatic and visceral adipose tissue 11BHSD1 expressions are markers of body wieght loss

after bariatric surgery.

Obesity ( Siver Spring) 2015; 23 (9) : 1856-63

 

Evolution of differentiated thyroid cancer : a decade of thyroidectomies in a single institution.

Eur Thyroid J 2014 3(3) : 197-201

 

Detection of thyroid papillary carcinoma lymph node metastases using one step nucleid acid

amplification ( OSNA): preliminary results.

J Invest Surg 2015; 28 (3) : 153-9

 

Morbidly healthy obese are not metabolic healthy but less metabolic imbalanced then those

with type 2 diabetes or dyslipidemia.

Obes Surg 2015; 25 (8) : 1380-91

 

Decreased lipasas and fatty acid and glicerol transporter could explain reduced fat in diabetic

morbidly obese.

Obesity ( Silver Spring) 2014; 22 : (11) : 2379-87

 

Chronic fistula after laparoscopic vertical gastrectomy

Cir Esp 2014; 92 (10) : 700-1

 

Iodine deficiency is higher in morbid obesity in comparision  with late after bariatric surgery

and non-obese women.

Obes Surg 2015; (1): 85-9

 

Adiponectin upregulates SHBG production: molecular mechanisms and potential implications.

Endocrinology 2014; 155 (8) : 2820-30

 

Haematological parameters and serum trace elements in healthy and unhealthy morbidly obese

Patients before and after gastric by-pass

Clin Nutr 2014, Apr 24. Pii:S0261-5614(14)00093-4. Doi :10.1016/j.clnu.2014.04.003

 

Bariatric Surgery in morbidly obese patients improves the atherogenic qualitative properties

of the plasma lipoproteins

Atherosclerosis. 2014 May;234(1):200-5..

 

SPECT/CT sentinel lymph node identification in papillary thyroid cancer : lymphatic

staging and surgical management improvement.

Eur J Nucl Med Mol Imaging 2013; 40 (11) : 1645-55

 

Robotic sleeve gastrectomy versus laparoscopic sleeve gastrectomy : a comparative study with

200 patients

Obes Surg 2013; 23(10) : 1501-7

 

Bariatric surgery outcomes in a European Centre of Excellence ( CoE)

Obes Sur 2013; 23 : 1324-1332

 

Soluble CD40 ligand in Morbidly obese patients

JAMA surg 2013; 148 (2) : 151-156

 

Surgical induced weight loss by gastric by-pass improves non alcoholic fatty liver disease

in morbid obese patients.

World J Hepatol 2012; 4 ( 12) : 382-8

 

Laparoscopic repair of a postadrenalectomy left-sided diaphragmatic hernia complicates by

chronic colon obstruction

Surg Endosc 2013; 27 (5): 1826-8

 

Bariatric surgery in adolescents

Cir Esp 2012; 90 (10): 619-25

 

A bariatric surgery programme in adolescents. Preliminary results.

Cir Esp 2013; 91 (10).: 685-7

 

The initial learninig curve for robotic-assisted sleeve gastrectomy : a surgeon´s experience

 while introducing the robotic technology in a bariatric surgery department

Minim Invasive Surg 2012; 2012: 347131

 

Single-port transumbilical laparoscopic cholecystectomy : a prospective randomized

comparision of clinical results of 140 cases.

Journal of Minimal Access Surgery 2011 ; 8 (3) : 74-78

 

Reinassance of acromegaly after bariatric surgery.

Endocrine 2013 : 43 (1): 239-41

 

Single-port transumbilical laparoscopic appendectomy : a preliminary multicentric comparative study in 87 patients with acute appendicitis.

Minim Invasive Surg 2012; 2012 : 492409

 

Gallbladder variceal  bleeding in a patient with alcoholic cirrhosis : a rare entity

Rev Esp Enferm Dig 2012; 104 (3) : 153-154

 

Alterations in the common pathway of coagulation during weight loss induced by gastric

by-pass in severly obese patients.

J Obesity ( Silver Spring ) 2012; 20 (5) : 1048-1056

 

Only C-reactive protein, but not TNF-α or IL6, reflects the improvement in inflammation after

bariatric surgery.

Obes Surg 2012; 22 : 131-139

 

Single port access ( SPA ) sleeve gastrectomy. Is it reasonable ?

JMAS ( Journal of Minimal Access Surgery)  2011; 7 : 156-7

 

La concentración sérica de LP ( A ) en la obesidad y su evolución tras la cirugía bariátrica

Endocrinol Nutr 2011, 58 : 2

 

The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in

The morbidly obese

Obes Surg 2010; 20 ( 5 ) : 623-32

 

Endoscopic management of drain inclusion in the gastric pouch after gastrojejunal leakage

after laparoscopic Roux-in-Y gastic by-pass for the treatment of morbid obesity ( LRYGBP )

Diagn Ther Endosc 2010 ;  2010 : 891345

 

Laparoscopic transumbilical cholecystectomy

Cir Esp 2010; 88 (4): 277-8

 

Increased expression and activity of hepatic lipase in the liver of morbidly obese adult patients in relation to lipid content.

Obesity Surgery 2009 ;19 ( 7 ): 894-904

 

Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis.

Obes Surg. 2009 ; 19 ( 5 ) : 608-16

 

Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight

loss in morbidly obese patients.

Obes Surg. 2009 ; 19 (10) : 1414-23

 

Colouterine fistula complicating diverticulitis in elderly women.

Int J Colorectal Dis. 2009; 24 (5) :599-600

 

Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgical induced weight loss in morbidly obese patients.

Obes Surg 2009; 19 ( 8 ) : 1150-8

 

Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patientsd with morbid obesity . Relationship with glucose abnormalities.

Metabolism 2009 ; 58 ( 12 ) : 1762-8

 

Lower zinc-alpha 2-glicoprotein production by adipose tissue and liver in obese patients

unrelated

to insulin resistence

J Clin Endocrinol Metab 2009 94 ( 11 ) : 4499-507

 

Niveles séricos de magnesio en población obesa : relación con la presencia de alteraciones

hidrocarbonadas, parámetros de resistencia a la insulina y evolución tras la pérdida ponderal

Endocrinol Nutr 2008; Supl 5 : 81

 

Lipoprotein lipase activity in the liver of morbidly obese patients

Int J Obesity 2008; 32 : 1450

 

Sleep breathing disorders in morbidly obese premenopausal women awaiting for bariatric surgery

International Journal of Obesity 2008; 32 ( suppl  ) : S22

 

Post-thymectomy combined treatment of prednisone and tracrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis : a non-randomized, non-controled study

Curr Med Res Opin 2007; 23( 6 )  : 1269-1278

 

Abnormal LPL and HSL activity in subcutaneous and visceral adipose tissue facilitate lipid storage in morbid obesity

Int J Obesity 2007; 9 ( 31 ) : 1486

 

Initial experience with 150 consecutive gastric bypass : an approach to the learninig curve of

bariatric procedures

Obesity and Metabolism 2007 ; 3 : 55-65

 

Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis

Curr Med Res Opin 2006; 22( 5 ) : 885-895

 

Evolution and improvement of risk factors associated with morbid obesity in bariatric surgery

Atheroclerosis  2006; 7 : 374

 

Long term results of tacrolimus in cyclosporine – and prednisone- dependent myasthenia gravis. Reply to Sanders et al

Neurology 2005; 64 (9): 1641 – 1643 .

 

Benefits of FK506 ( tacrolimus ) for residual, cyclosporin – and prednisone- resistant myasthenia gravis : one-year follow-up of an open-label study.

Clinical Neurol Neurosurg 2005; 107( 3 ) : 187-190

 

Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal

cancer. Results of a phase II study.

Br J Surg 1998; 85 ( suppl )  : 125

 

Fluorouracil and high-dose leucovorin with radiotherapy as adjuvant therapy for rectal cancer.

Dig Surg 1998; 15 : 533

 

Leyomioma of the duodenum

Dig Surg 1998; 15 : 450

 

Thymectomy in 330 patients with myasthenia gravis. Evaluation of prognostic factors.

Br J Surg 1997; 84 ( suppl ) : 151

 

Bowel habit after cholecystectomy : physiological changes and clinical implications

Gastroenterology 1996; 111( 3 ) : 617-622

 

Pronostic value of the histological classification in thymomas with myasthenia gravis.

Br J Surg 1996; 83 ( suppl 2 ) : 139

 

Does cholecystectomy disrupt gastrointestinal and colonic transit in man ?

Gastroenterology 1991; 100 : A 210

Estancias formativas en el extranjero

– Mayo Clinic. Rochester. Minnesota. U.S.A.

Agosto y Septiembre 1984

Actualización en técnicas quirúrgicas

 

– St. Mark’s Hospital. Londres. Inglaterra

Enero, Febrero y Marzo 1988

Especialización en Coloproctología.

 

– Gastro-Obeso Center. Sao Paulo. Brasil

Marzo 2009

Actualización en Cirugía Bariátrica y Metabólica

 

Lugar de trabajo / posición laboral

Hospital Vall d´Hebron de Barcelona. Jefe de la Unidad de Cirugía Endocrina, Metabólica y Bariátrica.

Grupo Quirón. Centro Médico Teknon Barcelona. Cirujano especialista

HD Delfos. Cirujano especialista.

Hospital General de Barcelona. Cirujano general del cuadro facultativo. Asistencia Sanitaria Colegial

 

Pertenencia a mutuas

 

Mutua Universal

Asistencia Sanitaria Colegial

Agrupació Mutua

DKV Previasa

Mutua General de Cataluña